165 related articles for article (PubMed ID: 36652464)
21. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial.
Prasad AS; Fitzgerald JT; Bao B; Beck FW; Chandrasekar PH
Ann Intern Med; 2000 Aug; 133(4):245-52. PubMed ID: 10929163
[TBL] [Abstract][Full Text] [Related]
22. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
23. A standardized polyphenol mixture extracted from poplar-type propolis for remission of symptoms of uncomplicated upper respiratory tract infection (URTI): A monocentric, randomized, double-blind, placebo-controlled clinical trial.
Esposito C; Garzarella EU; Bocchino B; D'Avino M; Caruso G; Buonomo AR; Sacchi R; Galeotti F; Tenore GC; Zaccaria V; Daglia M
Phytomedicine; 2021 Jan; 80():153368. PubMed ID: 33091857
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold.
Eccles R; Meier C; Jawad M; Weinmüllner R; Grassauer A; Prieschl-Grassauer E
Respir Res; 2010 Aug; 11(1):108. PubMed ID: 20696083
[TBL] [Abstract][Full Text] [Related]
25. Validation of a short form Wisconsin Upper Respiratory Symptom Survey (WURSS-21).
Barrett B; Brown RL; Mundt MP; Thomas GR; Barlow SK; Highstrom AD; Bahrainian M
Health Qual Life Outcomes; 2009 Aug; 7():76. PubMed ID: 19674476
[TBL] [Abstract][Full Text] [Related]
26. Evaluation on immediate analgesic efficacy and safety of Kai-Hou-Jian spray (children's type) in treating sore throat caused by acute pharyngitis and tonsillitis in children: study protocol for a randomized controlled trial.
Ma YN; Zhong CL; Hu SY; Cai QH; Guo SX
Trials; 2021 Mar; 22(1):216. PubMed ID: 33736674
[TBL] [Abstract][Full Text] [Related]
27. Effects of dietary supplementation with conjugated linoleic acid on experimental human rhinovirus infection and illness.
Peterson KM; O'Shea M; Stam W; Mohede IC; Patrie JT; Hayden FG
Antivir Ther; 2009; 14(1):33-43. PubMed ID: 19320235
[TBL] [Abstract][Full Text] [Related]
28. Time-to-onset of cold and flu symptom relief: A randomized, double-blind, placebo-controlled pilot study for a multi-symptom combination product.
Zhang Y; Mallefet P
Int J Clin Pharmacol Ther; 2018 Dec; 56(12):604-611. PubMed ID: 30220290
[TBL] [Abstract][Full Text] [Related]
29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial.
Turner RB; Wecker MT; Pohl G; Witek TJ; McNally E; St George R; Winther B; Hayden FG
JAMA; 1999 May; 281(19):1797-804. PubMed ID: 10340366
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy and safety of Regan Syrup in treatment of common cold (wind-heat syndrome):a multicenter, randomized, double-blind, double-dummy, placebo and positive drug-controlled, parallel, phase Ⅱb clinical trial].
Hu YM; Liu QQ; Chen S; Chen YY; Wang L; Liu N; Chen N; Long YY; Dong H
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2233-2240. PubMed ID: 37282911
[TBL] [Abstract][Full Text] [Related]
32. Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds.
Hayden FG; Kaiser DL; Albrecht JK
Antimicrob Agents Chemother; 1988 Feb; 32(2):224-30. PubMed ID: 2834996
[TBL] [Abstract][Full Text] [Related]
33. Clinical, double-blind, placebo-controlled study investigating the combination of acetylsalicylic acid and pseudoephedrine for the symptomatic treatment of nasal congestion associated with common cold.
Loose I; Winkel M
Arzneimittelforschung; 2004; 54(9):513-21. PubMed ID: 15500197
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial].
Kalyuzhin OV; Gorelov AV; Malyavin AG; Zaytsev AA; Esaulenko EV; Novak KE; Bykov AS
Ter Arkh; 2023 Nov; 95(10):850-858. PubMed ID: 38159017
[TBL] [Abstract][Full Text] [Related]
35. The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: a double blind randomized study.
Vitetta L; Coulson S; Beck SL; Gramotnev H; Du S; Lewis S
Complement Ther Med; 2013 Jun; 21(3):164-71. PubMed ID: 23642947
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial.
Predy GN; Goel V; Lovlin R; Donner A; Stitt L; Basu TK
CMAJ; 2005 Oct; 173(9):1043-8. PubMed ID: 16247099
[TBL] [Abstract][Full Text] [Related]
37. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial.
Yale SH; Liu K
Arch Intern Med; 2004 Jun; 164(11):1237-41. PubMed ID: 15197051
[TBL] [Abstract][Full Text] [Related]
38. Effects of creating a non-specific, virus-hostile environment in the nasopharynx on symptoms and duration of common cold.
Hull D; Rennie P; Noronha A; Poore C; Harrington N; Fearnley V; Passàli D
Acta Otorhinolaryngol Ital; 2007 Apr; 27(2):73-7. PubMed ID: 17608134
[TBL] [Abstract][Full Text] [Related]
39. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
40. Reply to Davison, G. Comment on "Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect
Huijghebaert S; Vanham G; Van Winckel M; Allegaert K
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
